Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

Recruiting

• Conditions: Tricuspid Valve Regurgitation; Complications, Longterm Outcome

• Registration Number: NCT06554119
• Lead Sponsor: Guangdong Provincial People's Hospital

Brief Summary

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Detailed Description

Not available

Study Timeline

• Study Start: 1999-01
• Status Verified: 2024-08
• Study First Submitted: 2024-08-13
• Study First Submitted QC: 2024-08-13
• Last Update Submitted: 2024-08-13
• Study First Posted: 2024-08-15
• Last Update Posted: 2024-08-15
• Primary Completion: 2025-01
• Study Completion: 2025-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 375

Inclusion Criteria

patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion Criteria

age <16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
death rate	1999-01 - 2025-01	perioperative and longterm
complications	1999-01 - 2025-01	perioperative and longterm complications

Secondary Outcome Measures

Name	Time	Method
redo of tricuspid valve	1999-01 - 2025-01	redo of tricuspid valve during the follow-up

Trial Locations

Locations (1)

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University; 🇨🇳 Guangzhou, Guangdong, China